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We are witnessing an increasing interest in peripheral vas-
cular disease among cardiologists. A field that had previ-
ously been left to the surgeons and radiologists in many
practice environments is now attracting participation by
cardiologists. Anthony D eMaria . MD commented on this
trend 3 years ago in a Presidents Page (!) and defined the
response of the American College of Cardiology . In this
President `s Page, 1 will expand on his excellent summary of
the issues involved and the continuing efforts of the ACC to
provide leadership in this area .
Changing perspective on the vascular component of heart
disease . Why is vascular disease now attracting so much
attention? My colleague . Jack Spinell, MD, has identified
the primary stimulus for [his trend as the lure of performing
angioplasty in the peripheral vascular system 12)
. No doubt
this is a major stimulus . however. i n my judgment . the
change in the types of disease that dominate the practice of
cardiologists also explains why peripheral vascular disease is
now of more importance to cardiologists. In my earliest days
of clinical cardiology practice, in the early 19GOs the pa-
tients were primarily those with congenital and yalvular
heart disease . There was little invcstigatioa in patients with
coronary artery disease because therapy was limited at that
time . Moreover, patients with acute myocardial infarction
were treated in an extremely conservative manner and, by
today's. standards. incorrectly. Although there was a high
prevalence of coronary heart disease, its vascular compo-
nent was not emphasized in the work of most cardiologists .
This was reflected in my own institution, the Mayo Clinic .
where sepamrn sections for cardiology and peripheral vas-
cular disease had been established .
Today . however, with the advances in early detection and
treatment of congenital heart disease, the near eradication of
rheumatic valvular disease . the introduction of coronary
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arteriography by Sones 0) and an aging population, the
eumpunents of adult clinical cardiology practice have
changed dramatically . Our most common clinical problems
are now truly vascular in origin. Furthermore, we are keenly
aware that the disease process is not confined to the heart
but frequently results in complicated clinical problems re-
ated to diffuse atherosclerosis . Thus the neat anatomic
boundaries of the heart (or proximal aorta) no longer provide
a clear distinction between "cardiology' and "vascular
medicine ." Our clinical practice now demands a recognition
of the true systemic nature of vascular disease as an impor-
tant pan of diagnostic and therapeutic strategies .
Education in vascular disease . Although as cardiologists
we ore keen to apply our technology to ,ratients with
peripheral vascular involvement, we have not demonstrated
a similar enthusiasm far emphasizing the broad educational
requirements to vascular disease in our training, As empha-
sized by Spittcll (2)- there are important medical aspects to
all vascular disease including the more unusual clinical
problems . I can attest to this having observed the superb
vascular clinicians in my own institution .
In addition. them is a growing awareness of the concept
of vascular biology in the broadest sense with integration of
knowledge that relates not only to the cardiovascular system
but also to pulmonary and blood-related processes . A recent
National Institutes of Health workshop on vascular biology
emphasized new horizons for research that hold great poten-
Iial for providing new insights into the diseases We treat as
clinicians- Particular emphasis is on the biology of the
endothelium and the vascular wall. In addition, the NIH has
recognized the importance of stimulating integration of edu-
cation and research programs and a broadened definition of
cardiovascular disease. Two new programs of the NIH will
address these new realities. The first is the Academic Award
in Systemic and Pulmonary Vascular Disease designed to
advance clinical care, research and education in the broadest
sense. The second is an announcement of competition for
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program project grants in Vascular Biology in Medicine. It is
hoped that such programs :,ill encourage proposals that will
stimulate innovative and interdisciplinary approaches to the
problems of vascular disease unrelated to arbitrary anatomic
boundaries .
These trends in clinical practice, education and research
should be sufficient tojustify an awakening of interest in the
cardiology community on the importance of vascular dis.
ease, even without the confrontation of turf issues that
unfortunately seem unavoidable in the practice arena .
Role of the ACC . How should the American College of
Cardiology respond? Under the leadership of then ACC
President DeMaria, the Board of Trustees agreed with the
Strategic Planning Committee that the College needed to
respond to these trends. Thus, in 1988 a Peripheral Vascular
Disease Committee was formed and Dr . lack Spittell was
asked to chair it . Just 3 years later, the Committee is active
in providing information and proposals to the ACC leader-
ship on practice and education issues. For instance, the
opportunities for ACC fellowship of individuals having a
primary interest in peripheral vascular disease have been
recognized by the Credentials Committee on the basis of
specific input by the Peripheral Vascular Disease Commit-
tee . In addition, the Committee is in the process of making
recommendations on important issues of training in periph-
eral vascular disease . As we consider vascular disease in the
broadest sense, the Strategic Planning Committee is also
examining the need for a committee on hypertension .
I want to highlight the role of the ACC in providing
leadership in achieving expanded training in vascular disease
within cardiology training programs . Training in peripheral
vascular disease should encompass bedside clinical exami .
nation and pathophysiology, not just imaging and interven,
ttonal training . At the same time . We need to expand training
JACC Vet, 10
. No
. 2
A
.,-
19vl:6a1-2
in hypertension and lipid disorders as well. For cardiologists
who do wish to establish expertise in interventional and
Imaging procedures in the peripheral vascular system, the
curriculum required to accomplish such credentials needs to
be clearly defined, ideally in collaboration with vascular
surgeons and radiologists . Although the subspecialty boards
in cardiac disease in adults have always been labeled "car-
diovascular," it is well recognized that the amount of formal
training in peripheral vascular disease is minimal to nonex-
istent in most adult cartcattegy fellowships . This needs to be
corrected . I personally believe it is essential for the Amen.
can Board of
Internal Medicine to be convinced of the need
to expand the recognition of vascular disease in the process
of board certification and to provide opportunities for dem-
onstration of special qualifications in vascular medicine
similar to those provided far physicians trained in electra .
physiology .
I strongly support the efforts to date of the ACC and urge
continued attention to this important issue of vascular med-
icine and its significance to cardiologists . We are off to a
good start, but without further emphasis on improving
education in vascular medicine in our cardiology programs,
and insisting on recognition of such special knowledge, we
will lose our influence on the practice, education and re-
search issues that confront us in a large component of our
practice .
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